Hispanic Health News
Lung Cancer and Hispanics: Know the Facts
Photo: Lung Cancer and Hispanics: Know the Facts
First, the good news: the number of lung cancer cases diagnosed in Hispanics is about half of the number for non-Hispanic whites in the United States. And from 2000 to 2009, the number of cases for Hispanic males declined at a faster rate than for non-Hispanic white men, and remained stable for Hispanic women. The primary reason for this good news is that Hispanics generally are less likely to smoke and are less likely to be daily cigarette smokers than many other segments of the American population.
However, lung cancer is still the leading cause of cancer death among Hispanic men and the second-leading cause among Hispanic women. November is Lung Cancer Awareness Month, a good time to separate myth from fact when it comes to lung cancer. So what are the facts?
-Smoking is the primary cause of lung cancer. Not smoking is the best way to prevent lung cancer. Quitting smoking greatly lowers the risk of cancer and other diseases.
About 90 percent of lung cancer cases in men and about 80 percent of those in women are caused by smoking. Smoking also causes many other cancers, including esophagus, throat, pancreatic, kidney, and bladder cancer, as well as heart disease, stroke, aortic aneurysm, chronic obstructive pulmonary disease, and other health problems. Overall, smoking causes almost half a million premature deaths every year in the United States.
-Free resources are available to help you quit smoking.
The National Cancer Institute’s Smoking Quitline lets you talk for free with a smoking cessation counselor. You can call 1-877-44U-QUIT (1-877-448-7848) toll free within the United States, Monday through Friday 8:00 a.m. to 8:00 p.m. Eastern Time.
1-800-QUIT-NOW, another free quitline, can provide smoking cessation counseling, a personalized quit plan and self-help materials, and the latest information about medications to help you quit.
On the Internet, NCI’s LiveHelp Online Chat (https://livehelp.cancer.gov/) allows you to get information and advice about quitting smoking through a confidential online text chat with an information specialist from the NCIs Cancer Information Service, Monday through Friday, 8:00 a.m. to 11:00 p.m. Eastern Time.
SmokefreeTXT (http://smokefree.gov/smokefreetxt) is a free text-messaging program that provides 24/7 encouragement, advice, and tips to help smokers stop smoking for good. The text program, which is available in Spanish and English, starts 2 weeks before your quit date and lasts for 6 weeks following your quit date. Normal carrier rates apply if you do not have unlimited text messaging.
Your healthcare provider can also provide support, resources, and medications to help you quit smoking.
-Screening with computed tomography (CT) can help reduce lung cancer deaths in heavy smokers.
In a recent clinical trial, called the National Lung Screening Trial (NLST), current and former heavy smokers were screened with low-dose helical computed tomography (CT) or chest X-rays. Those who were screened with low-dose CT were 20 percent less likely to die from lung cancer than those who were screened with chest X-rays. (Previous studies had shown that screening with chest X-rays does not reduce deaths from lung cancer.)
If you have smoked an average of a pack of cigarettes a day for 30 years and still smoke or stopped less than 15 years ago, you may want to talk with your healthcare provider about whether you should undergo lung cancer screening. Because the procedure is relatively new, it may not be covered by many health insurance policies. Also, as with any screening test, there are possible harms as well as benefits, including false alarms that lead to invasive tests or operations that could cause complications.
No other screening tests have been shown to reduce the risk of dying from lung cancer.
To learn more about lung cancer, visit the National Cancer Institute (NCI) Web site at www.cancer.gov (search term: lung) or call 1-800-4-CANCER (1-800-422-6237). NCI has a variety of information on lung cancer risk, prevention, screening, treatment, clinical trials, and a host of other topics.